The first question to consider when thinking about how to fund future research into Dupuytren Disease is what type of research do we wish to perform? Translational research covers the entire spectrum from basic laboratory research into fundamental genetics, cellular signalling pathways and cell biology; through epidemiological studies of environmental predisposition to disease; past studies of new potential treatments or preventative strategies (often first-in-man studies); to comparative studies of current treatments to determine the cost-utility of each form of treatment. All of these areas of enquiry have merit, and each can make a contribution to the understanding of Dupuytren Disease; so how can we prioritize which areas are funded?